ARK Space & Defense Innovation ETF vs InMode Ltd — how do they compare? ARK Space & Defense Innovation ETF trades at $34.49, while InMode Ltd trades at $15.19 (market cap $872.08M). The key difference: ARK Space & Defense Innovation ETF is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals.
| ARKX | INMD | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $37.74 | $16.62 |
52-Week Low | $25.46 | $12.76 |
Market Cap | — | $872.08M |
Enterprise Value | — | $375.42M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
InMode (INMD) trades at $15.17, down slightly by 0.13% today, with neutral technical signals and mixed earnings performance. The company maintains strong profitability with 76.52% gross margins and 20.69% net income margins, though Q1 2026 earnings missed expectations. Recent news highlights acquisition interest from Steel Partners at $16.75 per share and ongoing shareholder activism, creating both opportunity and uncertainty around corporate governance and valuation.
The stock presents a value opportunity with low P/E (12.52) and EV/EBITDA (5.37) multiples, but faces risks from earnings volatility, shareholder disputes, and potential undervaluation concerns. Analyst consensus leans neutral with 45% buy ratings, while technical indicators suggest range-bound trading near key support at $15. Investment appeal hinges on resolution of acquisition talks and sustained execution amid competitive pressures.
Trailing returns across standard periods
ARKX is an actively managed ETF that invests in companies leading space exploration and defense innovation. It focuses on orbital and sub-orbital aerospace, reusable rockets, and enabling technologies like AI, robotics, and satellite systems.
Read more on ARKX →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →